Pneumococcal Conjugate Vaccine and Pneumonia Prevention in Children with Congenital Heart Disease.

Background: A successful strategy to prevent Streptococcus pneumoniae infections is the administration of pneumococcal conjugate vaccines (PCVs).

Objective: To analyze the effectiveness of the 7- and 13-valent PCV for the prevention of all-cause pneumonia.

Materials And Methods: A retrospective cohort of children younger than 5 years of age, with congenital heart disease (CHD) and different vaccination schedules, was analyzed.

[Lung perfusion studies after percutaneous closure of patent ductus arteriosus using the Amplatzer Duct Occluder in children].

Objective: The closure of patent ductus arteriosus with multiple devices has been associated with a reduction in lung perfusion. We evaluated the pulmonary perfusion after percutaneous closure of patent ductus arteriosus with the Amplatzer Duct Occluder device using perfusion lung scan.

Methods: Thirty patients underwent successful percutaneous patent ductus arteriosus occlusions using the Amplatzer Duct Occluder device were included in this study.

[Percutaneous closure of the patent ductus arteriosus in children with the Amplatzer Duct Occluder II].

Introduction: In the last decades, several devices have been used for the percutaneous closure of patent ductus arteriosus, with its own limitations and risks. The Amplatzer Duct Occluder II has been designed to overcome those limitations and reduce risks.

Objective: We described our initial series of patients who underwent percutaneous closure of patent ductus arteriosus with the Amplatzer Duct Occluder II, emphasis on the technical aspects of the procedure.

[Percutaneous closure of patent ductus arteriosus using the Amplatzer vascular Plug II].

Unlabelled: The Amplatzer vascular II Plug (AVPII) is a self- expanding occluder device, indicated for arterial and venous occlusion in the peripheral circulation.

Objective: To describe our initial clinical experience with the AVP II, in the percutaneous closure of small patent ductus arteriosus.

Method: We retrospectively analyzed seven patients who underwent percutaneous closure of patent ductus arteriosus.

[Transcatheter closure of patent ductus arteriosus using the Amplatzer duct occluder in children: initial and one-year results].

Objective: Percutaneous closure of patent ductus arteriosus (PDA) is a well established technique. Our objective was to determine the safety and efficacy of the Amplatzer occluder for the treatment of PDA in children.

Methods: From November 2005 to June 2007 we reviewed the clinical records of 39 patients (23 girls and 16 boys), with a mean age of 19.

Transcatheter closure of patent ductus arteriosus using the amplatzer duct occluder in infants under 1 year of age.

Introduction And Objectives: Percutaneous closure of patent ductus arteriosus (PDA) is a well-established technique. We evaluated the usefulness of the Amplatzer duct occluder for the percutaneous closure of patent ductus arteriosus in 29 children under 1 year of age.

Methods: The patients' mean age was 8.

Transcatheter closure of patent ductus arteriosus using the amplatzer duct occluder in infants under one year of age.

Introduction And Objectives: Percutaneous closure of patent ductus arteriosus (PDA) is a well-established technique. We evaluated the usefulness of the Amplatzer duct occluder for the percutaneous closure of patent ductus arteriosus in 29 children under 1 year of age.

Methods: The patients' mean age was 8.

[Kawasaki disease: clinical behaviour and cardiovascular complications in children in a tertiary-care level hospital].

Objectives: To describe the clinical characteristics, outcome, and treatment response in a series of patients with Kawasaki disease (KD).

Methods: Case-series, review of clinical records of children with KD diagnosis cared for from november 1999 to september 2006.

Results: 22 patients were included, male:female ratio, 1.

[Balloon angioplasty for native aortic coarctation in children younger than 12 months: immediate and medium-term results].

Introduction And Objectives: The use of the balloon angioplasty (BA) in the treatment of patients with native aortic coarctation during childhood, particularly during the first 12 months of age, is controversial. The aim of this study was to report our experience with the use of this therapeutic technique and review the immediate and middle-term results in patients until 12 months age with native aortic coarctation and to identify those factors related with the outcome.

Material And Method: We review retrospectively the clinical records of 35 patients less than 12 months of age with diagnosis of native aortic coarctation who underwent balloon angioplasty as first choice treatment during an eight year span (1998-2005).

[Transcatheter occlusion of the patent ductus arteriosus with detachable coils: immediate results and intermediate-term follow-up].

Objective: To determine the success rate and safety of percutaneous closure of patent ductus arteriosus (PDA) with a detachable coil.

Methods: Forty-one children with small- to moderate-size PDA (maximum diameter < or = 4 mm) underwent percutaneous coil occlusion. The results were assessed by angiography and echocardiography.

[Right coronary artery fistula opening into right ventricle. Echocardiographic findings and interventional management. Report of a case].

Coronary artery fistula is a rare condition in which a communication exists between a coronary artery an a cardiac chamber or systemic vein. It causes an obligatory shunt from the high-pressure coronary artery to a lower-pressure cardiac chamber. We report a case of right coronary artery fistula draining into the right ventricle, echocardiographic features and interventional catheterization.